SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-20-315060
Filing Date
2020-12-11
Accepted
2020-12-10 18:21:57
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 d10330d424b4.htm 424B4 2315979
2 GRAPHIC g10330g00n89.jpg GRAPHIC 136497
3 GRAPHIC g10330g00q79.jpg GRAPHIC 160175
4 GRAPHIC g10330g01y89.jpg GRAPHIC 148980
5 GRAPHIC g10330g15s86.jpg GRAPHIC 43622
6 GRAPHIC g10330g22w41.jpg GRAPHIC 104813
7 GRAPHIC g10330g32g54.jpg GRAPHIC 160501
8 GRAPHIC g10330g36r58.jpg GRAPHIC 53783
9 GRAPHIC g10330g61a61.jpg GRAPHIC 83278
10 GRAPHIC g10330g70k61.jpg GRAPHIC 179894
11 GRAPHIC g10330g82g52.jpg GRAPHIC 124101
12 GRAPHIC g10330g84w70.jpg GRAPHIC 141990
13 GRAPHIC g10330g84x73.jpg GRAPHIC 85692
14 GRAPHIC g10330g87o48.jpg GRAPHIC 74375
15 GRAPHIC g10330g87s14.jpg GRAPHIC 112053
16 GRAPHIC g10330g95r87.jpg GRAPHIC 153475
  Complete submission text file 0001193125-20-315060.txt   4740826
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-251171 | Film No.: 201381699
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences